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Abstract The cellular isoform of prion protein (PrPC) is a
ubiquitous glycoprotein expressed by most tissues and with a
biological function yet to be determined. Here, we have used a
neuroblastoma cell model to investigate the involvement of PrP
in cell adhesion. Incubation of single cell suspension induced cell^
cell adhesion and formation of cell aggregates. Interestingly,
cells overexpressing PrP exhibit increased cation-independent
aggregation. Aggregation was reduced after phosphatidylinosi-
tol-specific phospholipase C release of the protein and by pre-
incubation of cells with an antibody raised against the N-terminal
part of PrPC. Our paradigm allows the study of the function of
PrP as an intercellular adhesion molecule and a cell surface
ligand or receptor. ß 2002 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
The agent responsible for the transmissible spongiform en-
cephalopathies (TSEs) is thought to be a protein called PrPSc
(scrapie isoform of prion protein) which represents a confor-
mational variant of the cellular isoform of the prion protein
(PrPC) [1]. PrPC is a ubiquitous glycoprotein expressed partic-
ularly at high levels by neuronal cells [2]. Its normal function
remains uncertain, although its localization on the cell surface
would be consistent with roles in cell adhesion, ligand uptake
or transmembrane signaling [3]. It has been also proposed that
PrPC could act during development, as its expression is de-
tectable early in embryogenesis and increases during develop-
ment [4,5].
Several GPI-anchored proteins are implicated in cell^cell
adhesion mechanisms, such as the Ca2-independent neural
cell adhesion molecule (N-CAM). Data reported recently are
consistent with a possible function of PrP as a cell adhesion or
recognition molecule. In particular, the binding between PrP
and putative receptor or ligand was recently demonstrated. In
these studies, the 67-kDa laminin receptor (LR), the 37-kDa
laminin receptor precursor (LRP) and the extracellular matrix
glycoprotein laminin seem to interact with PrP [6^8]. Laminin,
through its cell membrane receptors, is known to play a piv-
otal role in cell proliferation, neuronal death and di¡erentia-
tion [9,10]. Thus, it was proposed that the speci¢c interaction
between PrP and laminin, LR or LRP could have consequen-
ces for neurite outgrowth, neuronal survival and di¡erentia-
tion via an unknown signaling event [6,7,11]. A signal trans-
duction pathway associated with PrP has been partially
characterized and occurs via the tyrosine kinase p59fyn in
the fully di¡erentiated neuronal cells [12]. The p59fyn kinase
has been implicated in N-CAM-induced neurite outgrowth in
rat PC12 cells [13]. Interestingly, it has been postulated re-
cently that N-CAMs are also good candidates to interact
with PrPC in mouse neuroblastoma N2a cells [14]. Taken to-
gether, these data suggested that PrPC may act as a cell sur-
face ligand or receptor mediating cell signaling.
Herein, we demonstrate that PrP is involved in a cell adhe-
sion process that leads to intercellular aggregation. The cell^
cell adhesion mediated by PrP is cation-independent and is
inhibited by an antibody against the N-terminal part of PrP
or by treatment of cells with phosphatidylinositol-speci¢c
phospholipase C (PIPLC).
2. Materials and methods
2.1. Reagent and antibodies
Opti-modi¢ed Eagle’s medium (MEM), trypsin, geneticin, Lipofect-
amine were from Life Technologies Inc. (Cergy-Pontoise, France) and
fetal calf serum from Bio-Whitaker (Fontenay-sous-bois, France).
PIPLC was purchased from Roche Diagnostics (Meylan, France).
All other reagents were from Sigma (St Quentin Fallavier, France).
Rabbit polyclonal antibody P45^66, raised against the synthetic
peptide encompassing moPrP residues 45^66 (CGGNRYPPQGGTW-
GQPHGGGWGQ), has been described earlier [15]. In some experi-
ments, the antibody P45^66 was blocked by incubation with its spe-
ci¢c peptide for 30 min before use. Secondary antibodies were from
Jackson Immunoresearch (West Grove, PA, USA).
2.2. N2a cell cultures
The mouse neuroblastoma cell line N2a was stably transfected with
wild-type mouse Prnp-a cDNAs without (N2a #58 clone) or with
(N2a #37 clone) a 3F4 tag, as previously described [15]. Transfected
and untransfected N2a cells were grown in Opti-MEM containing
10% fetal calf serum and penicillin/streptomycin in an atmosphere
of 5% CO2/95% air. In some experiments, N2a cells were transiently
transfected with a cDNA encoding wild-type moPrP using Lipofect-
amine as recommended by the manufacturer, and used 48 h after
transfection.
2.3. Western blot
For Western blotting, cell lysates were electrophoresed on a 12%
sodium dodecyl sulfate (SDS)/glycine/polyacrylamide gel. Proteins
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were electroblotted onto Immobilon-P membranes and PrP was de-
tected by using the antibody P45^66 and a peroxidase-conjugated goat
anti-rabbit secondary antibody. The blots were developed using en-
hanced chemiluminescence (ECL).
2.4. Cell aggregation assay
Con£uent transfected or untransfected N2a cells were lightly trypsi-
nized (0.01%) for 5 min. The level of PrPC was not signi¢cantly
a¡ected after this treatment (data not shown). Single cell suspensions
were obtained by passing cells through a G23 gauge needle. Suspen-
sions were adjusted to a ¢nal concentration of 106 cells/ml in Opti-
MEM containing 5% fetal calf serum (FCS) and 5 Wg/ml DNase I.
Cells were seeded in 24-well plates and allowed to aggregate on a
rotary shaker at 90^100 rpm. Cell viability was checked by using a
trypan blue assay. More than 95% of the cells remain alive through-
out the procedure. After 40 min of agitation, cells were ¢xed by the
addition (v/v) of 4% paraformaldehyde, 0.1% glutaraldehyde in phos-
phate-bu¡ered saline (PBS). This ¢xation prevents the dissociation of
the aggregates and is responsible for the shrunken shape of the cells
under phase contrast. For quantitation of aggregation, cells were care-
fully resuspended and single cells were counted under phase contrast
microscopy. Aggregation is de¢ned as the ratio of single cells to the
total number of cells counted. A minimum of 600 cells was counted in
triplicate for each experiment. In some cases, inhibition assays were
conducted by adding to the cell suspension antibodies or metal che-
lators.
2.5. PIPLC treatment
Con£uent cells were rinsed with cold PBS, incubated for 2 h on ice
with the bacterial enzyme PIPLC (1 unit/ml in Opti-MEM) which
cleaves the diacylglycerol portion of the glycosyl-phosphatidylinositol
anchor, and then cell aggregation assays were performed as described
previously.
2.6. Statistical analysis
Comparisons were made with analysis of variance, followed by the
unpaired t-test. A value of P6 0.05 was considered statistically sig-
ni¢cant. Where t-test shows a signi¢cant di¡erence, this is indicated
by an asterisk.
3. Results and discussion
PrPC is a highly conserved cell surface glycoprotein ex-
pressed by a broad range of cells and in particular by neuro-
nal cells [2]. The normal function of PrPC is still uncertain but
may be related to metal ion transport or cellular response to
oxidative stress. In addition, due to its localization on the cell
surface, it has been suggested that PrPC might function as a
receptor or an adhesion molecule [3]. In an attempt to eval-
uate a putative role of PrPC in cell adhesion, we compared the
aggregation of single cells in suspension that expressed di¡er-
ent levels of PrPC.
We used the mouse neuroblastoma cell line N2a that endog-
enously expresses PrPC on its surface (Fig. 1A, lane 1) [16].
We transfected these cells to express high levels of PrPC and
then measured their ability to aggregate. The levels of PrPC
expressed in untransfected N2a and transfected N2a subclones
were compared by immunoblotting with P45^66 antibody
(Fig. 1A). Quanti¢cation of the signal revealed that N2a
clones #58 and #37 have four times the PrP level of untrans-
fected N2a cells. We assayed these di¡erent cell lines for ag-
gregation as described in Section 2. As shown in Fig. 1B, the
two N2a subclones overexpressing PrP showed an increased
aggregation in comparison with the untransfected cells. The
cell lines overexpressing PrP usually gave larger cellular ag-
gregates than untransfected cell lines (Fig. 1B). After quanti-
¢cation, we observed that overexpression of PrP in the two
N2a subclones #58 and #37 increased the cell aggregation by
approximately 30% compared to the untransfected cells (Fig.
2A). Cell aggregation was also increased (by 34%) when N2a
cells were transiently transfected which result in an overex-
pression of PrPC comparable to that of stably transfected
cells. These ¢ndings obtained in two di¡erent clones and in
a population of transiently transfected cells demonstrate that
PrPC promotes aggregation of N2a cells.
In order to con¢rm that PrPC on the cell surface partici-
pates in the cell aggregation observed here, aggregation was
assayed with untransfected N2a cells and transfected N2a cells
(clone #58) which were pretreated with PIPLC to remove cell
surface PrP (Fig. 2B). Release of PrPC was veri¢ed by West-
ern blotting analysis (data not shown). The pre-incubation of
N2a clone #58 cells with PIPLC reduced the formation of cell
aggregates to the level of that of the untransfected N2a cells
(Fig. 2B). Interestingly, the aggregation of untransfected N2a
cells seems not be a¡ected by PIPLC treatment. This suggests
that PrP expressed at an endogenous level is not the main cell
adhesion molecule in these cells. We demonstrated the speci-
¢city of the aggregation by treatment with an anti-PrP anti-
body (Fig. 3A). Treatment of N2a #37 cells with P45^66, a
polyclonal antibody raised against the N-terminal part of PrP,
signi¢cantly inhibits cell aggregation compared to the same
cells treated with the corresponding pre-immune sera or
Fig. 1. Detection of PrPC in di¡erent cell lines, and light microscop-
ic observation of cell aggregation. A: Cell lysates were analyzed by
Western blotting with the PrP N-terminal speci¢c antibody P45^66.
N2a cells (lane 1) were stably transfected with mouse PrP. Two sub-
clones of stably transfected cells were analyzed: subclone N2a #58
transfected with moPrP (lane 2) and subclone N2a #37 transfected
with 3F4-tagged moPrP (lane 3). The position of molecular size
marker protein is in kDa. B: The cultured cells were released from
the culture dish, incubated in a standard aggregation assay, ¢xed
and then photographed at low magni¢cation. The shrunken aspect
of the cells is a consequence of the ¢xation procedure. Untrans-
fected N2a cells (upper panel) aggregated less than transfected N2a
#58 cells (middle panel) or N2a #37 cells (lower panel).
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with the antibody P44^66 blocked by pre-incubation with its
speci¢c peptide. These data suggest that the N-terminal part
of PrP plays a role in the aggregation phenomenon. Taken
together, our results indicate that PrP could function as an
adhesion molecule responsible for increasing the aggregation
of PrP-overexpressing N2a cells.
Most molecules involved in cell adhesion can be classi¢ed
into three di¡erent families: the integrins, the cadherins and
the immunoglobulins superfamily (for reviews see [17,18]).
Most of these molecules mediate adhesion in a cation-depen-
dent manner. Ca2 and Mg2 in particular are involved in
these phenomena. PrPC is known to bind copper through its
octapeptide region in the N-terminal half of the protein [19].
More data are needed to con¢rm the relation between PrPC
and copper, but this ion seems to be involved both in the
acquisition of the conformation of the N-terminus of PrPC
through its binding to the repeat region [20,21] and in the
function of the PrPC [22^24]. To investigate a possible role
of metal ions in PrPC-mediated aggregation, we examined the
e¡ect of chelators on aggregation. As shown in Fig. 3B, ad-
dition of copper chelators (DTPA, neocuproin or bathocu-
proin) or a cation chelator (EDTA) during the assay had no
signi¢cant e¡ect, indicating that PrPC-mediated adhesion oc-
curs in a cation-independent manner.
The results presented here show that when PrP-overexpress-
ing N2a cells are in suspension, a speci¢c intercellular adhe-
sion occurs through cell surface PrP. This cell^cell adhesion is
cation-independent and is inhibited by an antibody against
the N-terminal part of PrP or by treatment of cells with
PIPLC. The cell aggregation is most likely mediated by the
speci¢c transcellular binding of PrPC on the surface of one cell
with an unknown molecule on the surface of the other. Many
studies have been conducted to identify PrPC-binding pro-
teins. Among the putative candidates, PrPC seems to interact
with the 37-kDa LRP and the 67-kDa LR [7,8], the extracel-
lular matrix glycoprotein laminin [6] and very recently with N-
CAMs [14]. All these data are consistent with a possible func-
tion of PrPC as a neuronal receptor and cell adhesion or
recognition molecule. Many putative N-CAMs have been im-
plicated in di¡erent developmental and cellular processes in-
Fig. 2. Quantitative analysis of N2a cell aggregation. A: Aggrega-
tion of untransfected or transfected N2a cells was assayed as de-
scribed in Section 2. Aggregation is expressed as the di¡erence in
percent of the aggregation of the cell lines calculated relative to that
of untransfected N2a cells (control). Each bar represents the
mean þ the standard deviation from at least three independent ex-
periments. Asterisks indicate signi¢cant di¡erences between control
and transfected cells (P6 0.05). B: Prior the aggregation assay, N2a
and N2a #58 cells were incubated in presence or absence of PIPLC.
Each bar represents the mean aggregation relative to untreated N2a
cells from three experiments. Asterisks indicate a signi¢cant
di¡erence between untreated and PIPLC-treated N2a #58 cells
(*P6 0.05).
Fig. 3. Quantitative analysis of aggregation in presence or absence
of antibodies or metal ion chelators. A: Aggregation of N2a #37
cells was performed in the absence of antiserum or in the presence
of pre-immune sera at 1/50, P45^66 polyclonal antibody at 1/50 or
P45^66 antibody blocked with its speci¢c peptide. B: Aggregation
of N2a #37 cells was performed in absence of chelator or in the
presence of 2 mM EDTA, 1 mM DTPA, 100 WM bathocuproin
(BC) or 100 WM neocuproin (NC). The amount of cell aggregation
with or without treatment was plotted. Each bar represents the
mean aggregation relative to untreated cells from three experiments.
Asterisks indicate signi¢cant di¡erences between untreated and
treated cells (**P6 0.01).
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cluding neurite outgrowth, neuronal cell migration, cell-to-cell
interaction or cell signaling (for reviews see [17,18]). Interest-
ingly, the PrP/laminin interaction seems to be important for
the neuritogenesis of cultured hippocampal neurons [6] and
for the di¡erentiation and neurite outgrowth of PC12 cells
[11]. Moreover, binding of PrPC to the LRP/LR receptor me-
diates the internalization of PrPC, a process which could be
linked to signal transduction events [7]. One could imagine
that the speci¢c intercellular adhesion mediated by PrPC in
our aggregation model could result in activation of an intra-
cellular signaling process similar to that observed in other
adhesion events [13,25]. In particular, PrPC has been impli-
cated recently in signal transduction activity via activation of
the tyrosine kinase p59fyn [12]. Further experiments are planed
to identify a possible signal transduction response after cell^
cell adhesion as shown in another model [26]. An additional
issue concerns the domain of PrP that is involved in adhesion.
Using antibodies as blocking agents in the aggregation assay,
we have shown that the N-terminal part of PrP containing the
octapeptide region is involved. In addition to binding copper,
this region also seems to bind heparin sulfate proteoglycans
(HSPGs) [27,28]. HSPGs are widely distributed in mammalian
tissues and play an essential role during neural development
(for review see [29]). Interestingly, it has been postulated that
HSPGs act as co-factors for PrP/LRP binding through a do-
main that encompasses residues 53^93 [30]. In conclusion, our
results point out the possible role of PrPC in cell adhesion and
recognition mechanisms. The intercellular aggregation medi-
ated by PrP in our model could provide insight into the in-
teractions between PrPC and its putative receptors, and to
identify the phenotypic modi¢cations triggered by this bind-
ing. These insights would contribute to a better understanding
of the role of normal and pathological PrP molecules.
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